Pulp and Periapical Tissue DiseaseNCT06713174
Interleukin 8 and10 Levels Changes in Teeth With Necrotic Pulp and Apical Periodontitis
A study testing Assessment of Interleukin 8 and 10 Level Changes Before and During Root Canal Treatment for Necrotic Pulp with Apical Periodontitis in people with Pulp and Periapical Tissue Disease and Patients With Pulp Necrosis and Apical Periodontitis, run by Faculty of Dental Medicine for Girls at 1 site in Egypt.
Trial summary
The goal of this observational study is to evaluate changes in interleukin 8 (IL-8) and interleukin 10 (IL-10) levels in gingival crevicular fluid (GCF) and periapical fluid during root canal treatment in patients with necrotic pulp and apical periodontitis. Read more about this study
- Who is it for?
- Ages 18 to 45 yearsHealthy volunteers can take part
- Conditions the study is for
- Pulp and Periapical Tissue Disease, Patients With Pulp Necrosis and Apical Periodontitis
- What is being tested?
- Assessment of Interleukin 8 and 10 Level Changes Before and During Root Canal Treatment for Necrotic Pulp with Apical Periodontitis
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 22 participants
- Where
- 1 siteEgypt
- Study dates
- 15 Dec 2024to 30 Mar 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Adult patients aged between 18 and 45 years.
- Patients without any systemic diseases.
- Patients diagnosed with pulp necrosis and apical periodontitis of a single root with a single canal who are seeking endodontic treatment.
- Patients who have not previously received endodontic treatment or any related therapeutic procedures.
- Patients with normal periodontal health.
- 1. Adult patients aged between 18 and 45 years. 2. Patients without any systemic diseases. 3. Patients diagnosed with pulp necrosis and apical periodontitis of a single root with a single canal who are seeking endodontic treatment. 4. Patients who have not previously received endodontic treatment or any related therapeutic procedures. 5. Patients with normal periodontal health.
- -
Who cannot join
- Patients who refuse to participate in the study.
- Patients who have been on long-term anti-inflammatory medication,received immunosuppressive chemotherapy or taken antibiotics within the last 3 weeks.
- Patients with systemic health conditions such as cardiovascular and respiratory diseases, diabetes mellitus, HIV infection, or hepatitis.
- Unrestorable teeth, pregnant women, and smokers will also be excluded from the study
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Assessment of Interleukin 8 and 10 Level Changes Before and During Root Canal Treatment for Necrotic Pulp With Apical Periodontitis
The goal of this observational study is to evaluate changes in interleukin 8 (IL-8) and interleukin 10 (IL-10) levels in gingival crevicular fluid (GCF) and periapical fluid during root canal treatment in patients with necrotic pulp and apical periodontitis. The main question it aims to answer is:
How do IL-8 and IL-10 levels in GCF and periapical fluid change over the course of treatment?
Participants will:
Provide samples of GCF and periapical fluid at two different time points during their root canal treatment.
Undergo treatment based on standard clinical protocols for necrotic pulp and apical periodontitis.
Read the detailed description
This observational study aims to investigate changes in biomarkers within gingival crevicular fluid (GCF) and periapical fluid during root canal treatment for patients with necrotic pulp and apical periodontitis. Ethical approval was obtained from the Research Ethics Committee (REC) of the Faculty of Dentistry for Girls at Al-Azhar University (P-EN-23-04). Written informed consent will be obtained from all participants after explaining the study's aims and importance.
Study Design:
Patients requiring root canal treatment at the Endodontic Clinic, Faculty of Dental Medicine for Girls, Al-Azhar University, will be recruited based on inclusion and exclusion criteria.
Inclusion Criteria:
Adults aged 18-45 years. Patients without systemic diseases. Patients diagnosed with necrotic pulp and apical periodontitis in a single-rooted tooth with a single canal.
Patients with no previous endodontic treatment or related therapeutic procedures.
Patients with normal periodontal health.
Exclusion Criteria:
Patients who decline participation. Patients on long-term anti-inflammatory medication, immunosuppressive chemotherapy, or antibiotics within the last 3 weeks.
Patients with systemic health conditions (e.g., cardiovascular diseases, diabetes mellitus, HIV, hepatitis).
Pregnant women, smokers, and those with unrestorable teeth.
Sample Collection Procedures:
- Gingival Crevicular Fluid (GCF): Timing: Samples will be collected at two time points: Before initiating access into the root canal (Period 1). Before canal filling (Period 2). Procedure: Isolation of the area using cotton rolls. Plaque removal and gentle air drying of the tooth. Placement of sterilized paper strips in the gingival sulcus until minimal resistance is felt. Strips will remain for one minute and will be placed on mesial or distal vestibular surfaces. If blood contamination occurs, collection will be attempted from another site. Persistent bleeding will lead to sample exclusion. Storage: Strips will be placed in Eppendorf tubes with phosphate-buffered saline and frozen at -80°C until analysis.
- Periapical Fluid:
Timing: Samples will be collected:
Just after crown access. Before root canal filling.
Procedure:
Three sequential sterile absorbent paper points will be inserted into the root canal, extending 2 mm beyond the radiographic apex.
Points will be left undisturbed for one minute. The tips (4 mm) will be cut and placed in Eppendorf tubes containing 2 mL of reduced transport fluid (RTF).
Storage:
Tubes will be stored at -80°C until analysis.
Root Canal Treatment Protocol:
Anesthesia and Isolation:
Local anesthesia with 2% lidocaine containing epinephrine 1:80,000. Rubber dam isolation.
Access and Cleaning:
Access cavity preparation using round tungsten carbide burs. Gates Glidden burs for straight-line access. Cleaning and shaping with stainless steel K-files. Irrigation with 10 mL of 2.5% sodium hypochlorite (total duration: 30 minutes). Final rinse with 2 mL of 17% EDTA for 1 minute, followed by 2 mL of sterile saline.
Sample Collection:
After initial preparation, samples from periapical fluid will be collected as described.
Temporary filling material will be used to seal the access cavity.
Completion of Treatment:
Seven days later, temporary fillings will be removed, and second samples of GCF and periapical fluid will be collected.
The root canals will be filled using gutta-percha and epoxy resin sealer via lateral compaction.
Composite resin will seal the access cavity.
Storage and Analysis:
All samples will be preserved at -80°C until biomarker analysis is performed. The study focuses on evaluating changes in key biomarkers (e.g., interleukins) associated with inflammation and healing during treatment.
This description ensures clarity, technical detail, and adherence to ethical and procedural standards, avoiding duplication of information from other sections
- Being tested
- Assessment of Interleukin 8 and 10 Level Changes Before and During Root Canal Treatment for Necrotic Pulp with Apical Periodontitis
- Keywords
- interleukin 8, interleukin 10, necrotic pulp, periodontitis
- Medical subject headings
- Periapical Periodontitis, Dental Pulp Necrosis, Periodontitis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Assessment of Interleukin 8 and 10 Level Changes Before and During Root Canal Treatment for Necrotic Pulp with Apical PeriodontitisDiagnostic test
This study will be performed to investigate interleukin-8 (IL-8) and interleukin-10 (IL-10) level changes in gingival crevicular fluid (GCF) and periapical fluid before and during root canal treatment (RCT) in patients with necrotic pulp and apical periodontitis. The null hypothesis tested will be There is no significant difference in (IL-8) and (IL-10) levels in gingival crevicular fluid (GCF) and periapical before and during root canal treatment (RCT) for necrotic pulp with apical periodontitis.
| Study group | Role | What they receive |
|---|---|---|
| assessment of interleukin 8,10 pre and post | Other | Gingival crevicular fluid sampling Gingival crevicular fluid (GCF) will be collected at two different time points. The collection periods will be defined as follows: before initiating access into the root canal (period 1), and before canal filling (period 2).
Periapical Fluid sample:
Periapical fluid samples will be collected at two different time points. The collection periods will be defined as follows: just after crown access and before root canal filling , by introducing 3 sequential sterile absorbent paper points of a size compatible with the root canal. These paper points will be introduced into the canal until they extend 2 mm beyond the radiographically determined apex. Receives: Diagnostic Test: Assessment of Interleukin 8 and 10 Level Changes Before and During Root Canal Treatment for Necrotic Pulp with Apical Periodontitis |
What is being measured
The primary outcome is the main question the study is designed to answer.
To assess changes in IL-8 and IL-10 levels in GCF and periapical fluid and evaluate if they are equivalent and can be used as markers of the inflammatory response before and during RCT.
Measured: The study will collect data at various time points, including baseline (pre-RCT) and during RCT.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Dec 2024
- Study start15 Dec 2024
- Primary completion15 Jan 2025
- Study completion30 Mar 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pulp and Periapical Tissue DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Diagnosis
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 22 participants (actual)
Sponsor and investigators
- Lead sponsor
- Faculty of Dental Medicine for Girls
- Sponsor type
- Other government
- Responsible party
- Principal investigator, Esraa Mohamed elsagheer Hassan, Faculty of Dental Medicine for Girls
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06713174
- Sponsor's protocol ID
- ENDOD-101-1-b
- Status last verified
- Feb 2026
- First submitted
- 25 Nov 2024
- Last updated
- 18 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 18 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Assessment of Interleukin 8 and 10 Level Changes Before and During Root Canal Treatment for Necrotic Pulp With Apical Periodontitis
- ClinicalTrials.gov ID
- NCT06713174
- Acronym / sponsor ID
- ENDOD-101-1-b
- Keywords
- interleukin 8, interleukin 10, necrotic pulp, periodontitis
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 22 participants (actual)
- Lead sponsor
- Faculty of Dental Medicine for GirlsOther government
- Study start
- 15 Dec 2024 (actual)
- Primary completion
- 15 Jan 2025 (actual)
- Study completion
- 30 Mar 2025 (actual)
- First posted
- 3 Dec 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this observational study is to evaluate changes in interleukin 8 (IL-8) and interleukin 10 (IL-10) levels in gingival crevicular fluid (GCF) and periapical fluid during root canal treatment in patients with necrotic pulp and apical periodontitis. The main question it aims to answer is:
How do IL-8 and IL-10 levels in GCF and periapical fluid change over the course of treatment?
Participants will:
Provide samples of GCF and periapical fluid at two different time points during their root canal treatment.
Undergo treatment based on standard clinical protocols for necrotic pulp and apical periodontitis.
Detailed description
This observational study aims to investigate changes in biomarkers within gingival crevicular fluid (GCF) and periapical fluid during root canal treatment for patients with necrotic pulp and apical periodontitis. Ethical approval was obtained from the Research Ethics Committee (REC) of the Faculty of Dentistry for Girls at Al-Azhar University (P-EN-23-04). Written informed consent will be obtained from all participants after explaining the study's aims and importance.
Study Design:
Patients requiring root canal treatment at the Endodontic Clinic, Faculty of Dental Medicine for Girls, Al-Azhar University, will be recruited based on inclusion and exclusion criteria.
Inclusion Criteria:
Adults aged 18-45 years. Patients without systemic diseases. Patients diagnosed with necrotic pulp and apical periodontitis in a single-rooted tooth with a single canal.
Patients with no previous endodontic treatment or related therapeutic procedures.
Patients with normal periodontal health.
Exclusion Criteria:
Patients who decline participation. Patients on long-term anti-inflammatory medication, immunosuppressive chemotherapy, or antibiotics within the last 3 weeks.
Patients with systemic health conditions (e.g., cardiovascular diseases, diabetes mellitus, HIV, hepatitis).
Pregnant women, smokers, and those with unrestorable teeth.
Sample Collection Procedures:
- Gingival Crevicular Fluid (GCF): Timing: Samples will be collected at two time points: Before initiating access into the root canal (Period 1). Before canal filling (Period 2). Procedure: Isolation of the area using cotton rolls. Plaque removal and gentle air drying of the tooth. Placement of sterilized paper strips in the gingival sulcus until minimal resistance is felt. Strips will remain for one minute and will be placed on mesial or distal vestibular surfaces. If blood contamination occurs, collection will be attempted from another site. Persistent bleeding will lead to sample exclusion. Storage: Strips will be placed in Eppendorf tubes with phosphate-buffered saline and frozen at -80°C until analysis.
- Periapical Fluid:
Timing: Samples will be collected:
Just after crown access. Before root canal filling.
Procedure:
Three sequential sterile absorbent paper points will be inserted into the root canal, extending 2 mm beyond the radiographic apex.
Points will be left undisturbed for one minute. The tips (4 mm) will be cut and placed in Eppendorf tubes containing 2 mL of reduced transport fluid (RTF).
Storage:
Tubes will be stored at -80°C until analysis.
Root Canal Treatment Protocol:
Anesthesia and Isolation:
Local anesthesia with 2% lidocaine containing epinephrine 1:80,000. Rubber dam isolation.
Access and Cleaning:
Access cavity preparation using round tungsten carbide burs. Gates Glidden burs for straight-line access. Cleaning and shaping with stainless steel K-files. Irrigation with 10 mL of 2.5% sodium hypochlorite (total duration: 30 minutes). Final rinse with 2 mL of 17% EDTA for 1 minute, followed by 2 mL of sterile saline.
Sample Collection:
After initial preparation, samples from periapical fluid will be collected as described.
Temporary filling material will be used to seal the access cavity.
Completion of Treatment:
Seven days later, temporary fillings will be removed, and second samples of GCF and periapical fluid will be collected.
The root canals will be filled using gutta-percha and epoxy resin sealer via lateral compaction.
Composite resin will seal the access cavity.
Storage and Analysis:
All samples will be preserved at -80°C until biomarker analysis is performed. The study focuses on evaluating changes in key biomarkers (e.g., interleukins) associated with inflammation and healing during treatment.
This description ensures clarity, technical detail, and adherence to ethical and procedural standards, avoiding duplication of information from other sections
Study design
- Primary purpose
- Diagnosis
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| assessment of interleukin 8,10 pre and post | Other | Diagnostic Test: Assessment of Interleukin 8 and 10 Level Changes Before and During Root Canal Treatment for Necrotic Pulp with Apical PeriodontitisGingival crevicular fluid sampling Gingival crevicular fluid (GCF) will be collected at two different time points. The collection periods will be defined as follows: before initiating access into the root canal (period 1), and before canal filling (period 2). Periapical Fluid sample: Periapical fluid samples will be collected at two different time points. The collection periods will be defined as follows: just after crown access and before root canal filling , by introducing 3 sequential sterile absorbent paper points of a size compatible with the root canal. These paper points will be introduced into the canal until they extend 2 mm beyond the radiographically determined apex. |
Who may qualify
- Ages
- 18 to 45 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (7 listed)
- Adult patients aged between 18 and 45 years.
- Patients without any systemic diseases.
- Patients diagnosed with pulp necrosis and apical periodontitis of a single root with a single canal who are seeking endodontic treatment.
- Patients who have not previously received endodontic treatment or any related therapeutic procedures.
- Patients with normal periodontal health.
Key exclusion criteria (4 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Assessment of Interleukin 8 and 10 Level Changes Before and During Root Canal Treatment for Necrotic Pulp with Apical PeriodontitisThis study will be performed to investigate interleukin-8 (IL-8) and interleukin-10 (IL-10) level changes in gingival crevicular fluid (GCF) and periapical fluid before and during root canal treatment (RCT) in patients with necrotic pulp and apical periodontitis. The null hypothesis tested will be There is no significant difference in (IL-8) and (IL-10) levels in gingival crevicular fluid (GCF) and periapical before and during root canal treatment (RCT) for necrotic pulp with apical periodontitis. | Diagnostic test | assessment of interleukin 8,10 pre and post |
Primary outcome
To assess changes in IL-8 and IL-10 levels in GCF and periapical fluid and evaluate if they are equivalent and can be used as markers of the inflammatory response before and during RCT.
Time frame: The study will collect data at various time points, including baseline (pre-RCT) and during RCT.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Feb 2026.
- Individual participant dataSharing planned: No
Related trials for Pulp and Periapical Tissue Disease
Not yet recruiting
Clinical and Radiographic Success of Calcium Hydroxide-Iodoform Paste Versus Modified Triple Antibiotic Paste for Necrotic Primary Molars in Children
Dental Pulp Necrosis, Periapical Diseases
Not yet recruitingObservational study
Comparative Analysis of Diagnostic Accuracy and Case Difficulty Assessment of Three Large Language Models
Pulp and Periapical Tissue Disease
Not yet recruitingEarly Phase 1
Chloramphenicol, Tetracycline, Zinc Oxide and Eugenol Paste (CTZ Paste) for Emergency Dental Treatment in Public Health Settings: A Randomized Trial
Pulp Disease, Dental, Pulp Necrosis
Active, not recruitingObservational study
Gingival Crevicular Fluid Biomarkers and Healing After Root Canal Treatment in Asymptomatic Apical Periodontitis
Pulp and Periapical Tissue Disease
RecruitingObservational study
Professional Practices Regarding Treatment of Non-vital Primary Teeth Among Dental Surgeons in France
Pulpitis - Irreversible, Pulp Necrosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Assessment of Interleukin 8 and 10 Level Changes Before and During Root Canal Treatment for Necrotic Pulp with Apical Periodontitis in people with Pulp and Periapical Tissue Disease and Patients With Pulp Necrosis and Apical Periodontitis, run by Faculty of Dental Medicine for Girls at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
To assess changes in IL-8 and IL-10 levels in GCF and periapical fluid and evaluate if they are equivalent and can be used as markers of the inflammatory response before and during RCT. (time frame: The study will collect data at various time points, including baseline (pre-RCT) and during RCT.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Feb 2026.